Sign in
The image displays a blister pack of "NIPHAMSHIN" Oxytracycline Capsules BP 250mg. The blister pack is silver and red, with text printed in both English and what appears to be a Nigerian NAFDAC registration number. The text indicates that the product is a "Quality Product of EMBASSY PHARMACEUTICAL & CHEMICALS LTD. Lagos Nigeria". It also states that the capsules are "MANUFACTURED IN INDIA BY LABORATE PHARMACEUTICALS INDIA LTD." The manufacturing and expiry dates are visible at the bottom: MFG. 03/2025 and EXP. 02/2028. The scene is a close-up shot of the blister pack resting on a light-colored, textured surface, likely a table, under indoor lighting. There are no people or specific locations in Jalingo, Nigeria, depicted in this image.
FM-zwv5T2

Jun 27, 2026, 4:58 PM

Jalingo, Nigeria

Moment

Stake attention in this memory

health
medicine
pharmaceutical
treatment
care

The image displays a blister pack of "NIPHAMSHIN" Oxytracycline Capsules BP 250mg. The blister pack is silver and red, with text printed in both English and what appears to be a Nigerian NAFDAC registration number. The text indicates that the product is a "Quality Product of EMBASSY PHARMACEUTICAL & CHEMICALS LTD. Lagos Nigeria". It also states that the capsules are "MANUFACTURED IN INDIA BY LABORATE PHARMACEUTICALS INDIA LTD." The manufacturing and expiry dates are visible at the bottom: MFG. 03/2025 and EXP. 02/2028. The scene is a close-up shot of the blister pack resting on a light-colored, textured surface, likely a table, under indoor lighting. There are no people or specific locations in Jalingo, Nigeria, depicted in this image.

Symbol

7DAB7

Volume

1,566

Creator

+$0.00

Revenue

+$0.00

TVL

$0.08

1D
1W
1M
All

Loading AttnAds…

transactions
revenues
stakers
Earliest
Latest
Highest stake

1

FM-FzB8r2

Staked 2mo ago

$0.07 USD

+$0.00 USD

+1.0%

2

Rev Bot 🤖💰

Injected revenue 2mo ago

Revenue bonus for the last stake.

+$0.00 USD

More from this user

More from Jalingo

FM-zwv5T2

Jun 27, 2026, 4:58 PM

Jalingo, Nigeria

Licensed under Creative Commons Attribution 4.0 International License. You are free to share and adapt this content with proper attribution.